Walleye Capital LLC Intra Cellular Therapies, Inc. Call Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$67.99 - $80.84 $156,377 - $185,932
-2,300 Reduced 21.1%
8,600 $628,000
Q2 2024

Aug 14, 2024
BUY
$64.76 - $79.84 $679,980 - $838,320
10,500 Added 2625.0%
10,900 $746,000
Q1 2024

May 15, 2024
SELL
$64.37 - $75.65 $38,622 - $45,390
-600 Reduced 60.0%
400 $27,000
Q4 2023

Feb 14, 2024
BUY
$46.37 - $73.65 $4,637 - $7,365
100 Added 11.11%
1,000 $71,000
Q2 2023

Aug 14, 2023
BUY
$54.67 - $66.44 $27,335 - $33,220
500 Added 125.0%
900 $56,000
Q1 2023

May 15, 2023
SELL
$43.8 - $56.99 $416,100 - $541,405
-9,500 Reduced 95.96%
400 $21,000
Q4 2022

Feb 14, 2023
SELL
$44.07 - $54.45 $453,921 - $560,835
-10,300 Reduced 50.99%
9,900 $523,000
Q3 2022

Nov 14, 2022
BUY
$42.7 - $59.99 $862,540 - $1.21 Million
20,200 New
20,200 $940,000
Q1 2020

May 15, 2020
SELL
$12.31 - $33.12 $1.43 Million - $3.86 Million
-116,400 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$7.26 - $38.49 $276,606 - $1.47 Million
38,100 Added 48.66%
116,400 $3.99 Million
Q3 2019

Nov 14, 2019
BUY
$7.47 - $14.03 $584,901 - $1.1 Million
78,300 New
78,300 $585,000
Q2 2019

Aug 14, 2019
SELL
$10.65 - $14.29 $10,650 - $14,290
-1,000 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$10.9 - $14.09 $10,900 - $14,090
1,000 New
1,000 $12,000

Others Institutions Holding ITCI

# of Institutions
384
Shares Held
84.9M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email